Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Methodological standard · §5

CEI-MS-09 — system suitability and acceptance criteria

The performance the system must demonstrate, and the criteria a result must meet to be reportable.

Document identifier
CEI-MS-09/5
Series
Methodological standard
Version
1.0
Published
13 Sep 2024
Last reviewed
13 Sep 2025
Next review
13 Sep 2028
Identifier
10.71829/cei.meth.15
Certainty
High
Cycle
2024 Q3
Category
Physical quality

§5System suitability and acceptance criteria

§5.1System suitability

Table 1. System suitability criteria. A determination is reportable only where every criterion is met at the time of analysis.

ParameterCriterionWhat it establishes
Illumination at the inspection point2000–3750 luxDetection sensitivity
Observer qualificationDocumented visual acuity assessmentInspection reliability
Diluent blankFree of visible particulateDiluent suitability

§5.2Acceptance criteria

  • A collapsed cake, a colour inconsistent with the compound, visible particulate in the reconstituted solution, or a reconstitution time exceeding the stated limit is recorded as a finding and reported.
  • This determination is never sufficient on its own, and is never omitted: it is the only assessment in the series that requires no instrument and it detects failures that instrumental methods can miss.

§5.3Limitations

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. United States Pharmacopeial Convention. General Chapter ⟨788⟩ Particulate Matter in Injections. United States Pharmacopeia — National Formulary (USP–NF) 2024;USP 2024 Issue 1. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.